Docetaxel: all 1,319 studies that test it

Page 4 of 14. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.

• Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract CarcinomasTerminatedNCT00532441Phase 2Results posted
• Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyCompletedNCT00528866Phase 2Results posted
• Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction PatientsCompletedNCT00526110Phase 1/2Results posted
• Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00524459Phase 2Results posted
• Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung CancerTerminatedNCT00520845Phase 2Results posted
• Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaCompletedNCT00515411Phase 2Results posted
• A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)TerminatedNCT00514917Phase 3Results posted
• Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate CancerCompletedNCT00514540Phase 2Results posted
• Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerTerminatedNCT00509366Phase 2Results posted
• Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum CarcinomaCompletedNCT00504257Phase 2Results posted
• Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate CancerCompletedNCT00500110Phase 2Results posted
• NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast CancerCompletedNCT00499122Phase 2Results posted
• Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLCCompletedNCT00499109Phase 3Results posted
• E3-Hormone Refractory Prostrate Cancer Taxotere CombinationCompletedNCT00498797Phase 2Results posted
• Adj TC + Herceptin Early Stage Breast CancerCompletedNCT00493649Phase 2Results posted
• Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00488982Phase 2Results posted
• Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell CancerCompletedNCT00485485Phase 2Results posted
• Docetaxel in Treating Patients With Relapsed Prostate CancerTerminatedNCT00482274Phase 2Results posted
• Salvage Radiation Therapy and Taxotere for PSA Failure After Radical ProstatectomyTerminatedNCT00480857Phase 2Results posted
• Randomized Customized Adjuvant Chemotherapy (GECP-SCAT)CompletedNCT00478699Phase 3Results posted
• A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to BrainTerminatedNCT00476827Phase 2Results posted
• A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer PatientsCompletedNCT00466440Phase 2Results posted
• Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast CancerCompletedNCT00464646Phase 2Results posted
• The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate CancerCompletedNCT00459186Phase 1/2Results posted
• Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate CancerCompletedNCT00456989Phase 1/2Results posted
• Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid TumorCompletedNCT00454649Phase 1Results posted
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By SurgeryCompletedNCT00448760Phase 2Results posted
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By SurgeryTerminatedNCT00448682Phase 2Results posted
• Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach CancerCompletedNCT00446290Phase 1Results posted
• Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate CancerCompletedNCT00439270Phase 1/2Results posted
• Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer PatientsCompletedNCT00432172Phase 2Results posted
• Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerActive, not recruitingNCT00430183Phase 3Results posted
• Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) PatientsCompletedNCT00428922Phase 2Results posted
• Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic CancerTerminatedNCT00426127Phase 2Results posted
• Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00425750Phase 2Results posted
• Neo-adjuvant Chemotherapy in Locally Advanced Gastric CancerCompletedNCT00414271Phase 2Results posted
• Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung CancerTerminatedNCT00406276Phase 1/2Results posted
• Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast CancerCompletedNCT00404066Phase 2Results posted
• Study of Induction Docetaxel, Cisplatin and 5-FluorouracilTerminatedNCT00400205Phase 2Results posted
• Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerCompletedNCT00394433Phase 2Results posted
• Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00390429Phase 1/2Results posted
• Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaCompletedNCT00390416Phase 2Results posted
• Docetaxel and Oxaliplatin in Gastric CancerCompletedNCT00382720Phase 2Results posted
• Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerTerminatedNCT00378573Phase 2Results posted
• Docetaxel and Epirubicin in Advanced Gastric CancerCompletedNCT00375999Phase 2Results posted
• Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 PositiveCompletedNCT00372424Phase 1Results posted
• Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast CancerCompletedNCT00365417Phase 2Results posted
• Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast CancerCompletedNCT00365365Phase 2Results posted
• Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung CancerCompletedNCT00362882Phase 2Results posted
• Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00356122Phase 2Results posted
• Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity CancerTerminatedNCT00354601Phase 2Results posted
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerTerminatedNCT00352118Phase 2Results posted
• Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate CancerTerminatedNCT00348816Phase 2Results posted
• Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerTerminatedNCT00343512Phase 2Results posted
• Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic CancerCompletedNCT00331682Phase 2Results posted
• Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical ProstatectomyCompletedNCT00321646Phase 2Results posted
• Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas CancerCompletedNCT00320749Phase 1Results posted
• Docetaxel in Breast CancerCompletedNCT00312208Phase 3Results posted
• Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerCompletedNCT00309985Phase 3Results posted
• Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00301808Phase 2Results posted
• TEACO: Taxotere, Eloxatin, Avastin in Cancer of the OvaryCompletedNCT00296816Phase 2Results posted
• Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast CancerCompletedNCT00291577Phase 1Results posted
• Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic CancerCompletedNCT00290693Phase 2Results posted
• Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate CancerCompletedNCT00288080Phase 3Results posted
• S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerTerminatedNCT00288054Phase 1Results posted
• Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical ProstatectomyCompletedNCT00283062Phase 3Results posted
• Adjuvant Chemotherapy for High Risk Uterine LeiomyosarcomaCompletedNCT00282087Phase 2Results posted
• Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00281840Phase 2Results posted
• Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLCCompletedNCT00280735Phase 2Results posted
• Individualized Drug Treatment for Treating Patients With Pancreatic CancerTerminatedNCT00276744Phase 2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00276549Phase 2Results posted
• Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung CancerCompletedNCT00271505Phase 2Results posted
• Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial CancerCompletedNCT00258362Phase 2Results posted
• Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant MelanomaCompletedNCT00256282Phase 2Results posted
• Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction CancerCompletedNCT00253370Phase 2Results posted
• A Study of Imatinib and Docetaxel in Prostate CancerCompletedNCT00251225Phase 2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck CancerCompletedNCT00248560Phase 2Results posted
• Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLCTerminatedNCT00238615Phase 2Results posted
• Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBCCompletedNCT00236899Phase 3Results posted
• Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung CancerCompletedNCT00231465Phase 2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal CancerCompletedNCT00227721Phase 2Results posted
• Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck CancerCompletedNCT00226239Phase 2Results posted
• Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate CancerCompletedNCT00225420Phase 1/2Results posted
• Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction CancerCompletedNCT00217581Phase 2Results posted
• Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung CancerCompletedNCT00216125Phase 3Results posted
• The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung CancerCompletedNCT00215930Phase 2Results posted
• Randomized Phase II Trial Induction Therapy for Early Stage Breast CancerCompletedNCT00209092Phase 2Results posted
• Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer PatientsCompletedNCT00206518Phase 2Results posted
• Primary Systemic Therapy in Operable/Locally Advanced Breast CancerCompletedNCT00203502Phase 2Results posted
• A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer PatientsCompletedNCT00201825Phase 2Results posted
• Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung CancerCompletedNCT00193453Phase 2Results posted
• Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung CancerCompletedNCT00193427Phase 2Results posted
• Docetaxel Plus Imatinib Mesylate in Metastatic Breast CancerCompletedNCT00193180Phase 2Results posted
• Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast CancerCompletedNCT00193050Phase 2Results posted
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast CancerCompletedNCT00193037Phase 2Results posted
• Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00191139Phase 2Results posted
• Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00184028Phase 2Results posted
• Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate CancerTerminatedNCT00183937Phase 2Results posted
• Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00183872Phase 2Results posted
• A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus CancersTerminatedNCT00177255Phase 2Results posted

← Docetaxel overview